NCT00280917 - Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients | Biotech Hunter

Enrollment

254

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions

Rheumatoid Arthritis

Interventions

DRUG

CF101

Trial Locations (35)

1233

Can-Fite Investigational Site, Sofia

1612

Can-Fite Investigational Site, Sofia

4002

Can-Fite Investigational Site, Plovdiv

6000

Can-Fite Investigational Site, Stara Zagora

11000

Can-Fite Investigational Site, Belgrade

11080

Can-Fite Investigational Site, Zemun

12206

Can-Fite Investigational Site, Albany

18205

Can-Fite Investigational Site, Niška Banja

31096

Can-Fite Investigational Site, Haifa

43551

Can-Fite Investigational Site, Perrysburg

44195

Can-Fite Invesitigational Site, Cleveland

44281

Can-Fite Investigational Site, Kfar Saba

52621

Can-Fite Investigational Site, Tel Litwinsky

70300

Can-Fite Investigational Site, Beer Yaakov

77479

Can-Fite Investigational Site, Sugar Land

Can-Fite Investigational Site, Haifa

78278

Can-Fite Investigational Site, Ashkelon

85381

Can-Fite Investigational Site, Peoria

91031

Can-Fite Investigational Site, Jerusalem

91120

Can-Fite Investigational Site, Jerusalem

400006

Can-Fite Investigational Site, Cluj-Napoca

500356

Can-Fite Investigational Site, Brasov

700661

Can-Fite Investigational Site, Iași

Unknown

Can-Fite Investigational Sites, Afula

Can-Fite Investigational Site, Jerusalem

15-297

Can-Fite Investigational Site, Bialystok

20-022

Can-Fite Investigational Site, Lublin

81-759

Can-Fite Investigational Site, Sopot

71-252

Can-Fite Investigational Site, Szczecin

020125

Can-Fite Investigational Site, Bucharest

020983

Can-Fite Investigational Site, Bucharest

01023

Can-Fite Investigational Site, Kiev

01103

Can-Fite Investigational Site, Kiev

03680

Can-Fite Investigational Site, Kiev

04053

Can-Fite Investigational Site, Kiev